|Quantity Discounts||1 - 2|
|3 - 4|
|5 - 6|
|7 - 9|
|10 - 9999|
Pediatric Clinical Trials Regulation: Latest FDA and International Compliance Developments
What do drug developers need to know about regulatory changes to pediatric trials?
Join Dr. Martine Dehlinger-Kremer — Global Vice President, Medical & Regulatory Affairs at SynteractHCR — for a 90-minute session where she’ll help attendees understand the landscape for pediatric drug development.
After listening to this webinar, you’ll be able to:
Understand the regulations you need to comply with in order to submit your pediatric drugs for approval. Order today.
Dr. Martine Dehlinger-Kremer, Global Vice President, Medical & Regulatory Affairs, SynteractHCR
In addition to providing top-level leadership for her company to the Medical and Regulatory Affairs functions, inclusive of Medical Operations, Feasibility, Medical Advice, Medical Monitoring, and Regulatory Affairs, Dr. Dehlinger-Kremer is also Chair of the Pediatric Working Group of EUCROF, the EU CRO Federation. She is also an active member of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) and an active member of the EFGCP Children Working Party.
Copyright ©2017. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing